Audited Supplier
MD
IVD Reagent
Rapid Test Cup of Dipstick Card
Urine
Within 5 Mins
2~30 º C
Immunochromatography
24 Months
CE
Professional Used
Dewei
25tests/Box; 40tests/Box
1000tests/carton
China
Product Description
INTENDED USE
The Multi-drug test is rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:
For other drugs, you can send mail or call us.
PRINCIPLE
Rapid Multi-Drug Test is a competitive immunoassay that is used to screen for the presence of various drugs and drug metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into each test strip by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test strip. This produces a colored Test line in the Test Region (T) of the strip, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C), of each strip, if the test has been performed properly.
STORAGE
The kit should be stored at 2-30°C until the expiry date printed on the sealed pouch.
The test must remain in the sealed pouch until use.
Keep away from direct sunlight, moisture and heat.
Do not freeze.
Care should be taken to protect the components of the kit from contamination. Do not use if there is evidence of microbial contamination or precipitation. Biological contamination of dispensing equipment, containers or reagents can lead to false results.
OPERATION
Allow the test device, specimen, buffer, and/or controls to equilibrate to room temperature (15-30°C) prior to testing.
| Parameter | Calibrator |
| THC | 11-nor-D9-THC-9-COOH |
| COC | Benzoylecgonine |
| PCP | Phencyclidine |
| OPI | Morphine |
| MET | Methamphetamin |
| MTD | Methadone |
| AMP | Amphetamine |
| BAR | Secobarbital |
| BZO | Oxazepam |
| TCA | Nortriptyline |
| MDMA | 3,4-Methylenediioxy-MET |
| BUP | BUP-3-D-Glucuronide |
| BUP | BUP-3-D-Glucuronide |
| EDDP | EDDP |
| OPI/MOP | Morphine |
| KET | Ketamine |
| TRA | Tramadol |
| FYL | Fentanyl |
| COT | Cotinine |
PRINCIPLE
Rapid Multi-Drug Test is a competitive immunoassay that is used to screen for the presence of various drugs and drug metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into each test strip by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test strip. This produces a colored Test line in the Test Region (T) of the strip, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C), of each strip, if the test has been performed properly.
STORAGE
The kit should be stored at 2-30°C until the expiry date printed on the sealed pouch.
The test must remain in the sealed pouch until use.
Keep away from direct sunlight, moisture and heat.
Do not freeze.
Care should be taken to protect the components of the kit from contamination. Do not use if there is evidence of microbial contamination or precipitation. Biological contamination of dispensing equipment, containers or reagents can lead to false results.
OPERATION
Allow the test device, specimen, buffer, and/or controls to equilibrate to room temperature (15-30°C) prior to testing.
PRODUCT IMAGES
R&D TEAM
PRODUCTION LINE
CERTIFICATES
EXHIBITIONS
SHIPMENTS
